TXG Annual Accounts Payable
$15.74 M
-$5.86 M-27.14%
31 December 2023
Summary:
As of January 22, 2025, TXG annual accounts payable is $15.74 million, with the most recent change of -$5.86 million (-27.14%) on December 31, 2023. During the last 3 years, it has risen by +$11.03 million (+234.21%). TXG annual accounts payable is now -27.14% below its all-time high of $21.60 million, reached on December 31, 2022.TXG Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Quarterly Accounts Payable
$26.21 M
+$4.96 M+23.35%
30 September 2024
Summary:
As of January 22, 2025, TXG quarterly accounts payable is $26.21 million, with the most recent change of +$4.96 million (+23.35%) on September 30, 2024. Over the past year, it has increased by +$7.37 million (+39.15%). TXG quarterly accounts payable is now -95.07% below its all-time high of $531.18 million, reached on December 1, 2014.TXG Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.1% | +39.1% |
| 3 y3 years | +234.2% | +51.1% |
| 5 y5 years | +79.0% | +101.2% |
TXG Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.1% | at low | -10.6% | +66.5% |
| 5 y | 5-year | -27.1% | +234.2% | -10.6% | +456.6% |
| alltime | all time | -27.1% | +234.2% | -95.1% | +456.6% |
10x Genomics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $26.21 M(+23.4%) |
| June 2024 | - | $21.25 M(+5.1%) |
| Mar 2024 | - | $20.22 M(+28.5%) |
| Dec 2023 | $15.74 M(-27.1%) | $15.74 M(-16.4%) |
| Sept 2023 | - | $18.84 M(-18.5%) |
| June 2023 | - | $23.12 M(-21.1%) |
| Mar 2023 | - | $29.32 M(+35.7%) |
| Dec 2022 | $21.60 M(+24.5%) | $21.60 M(+0.0%) |
| Sept 2022 | - | $21.59 M(-19.2%) |
| June 2022 | - | $26.73 M(+41.0%) |
| Mar 2022 | - | $18.96 M(+9.3%) |
| Dec 2021 | $17.35 M(+268.5%) | $17.35 M(+1.8%) |
| Sept 2021 | - | $17.04 M(+5.3%) |
| June 2021 | - | $16.18 M(+3.9%) |
| Mar 2021 | - | $15.58 M(+230.8%) |
| Dec 2020 | $4.71 M | $4.71 M(-50.4%) |
| Sept 2020 | - | $9.49 M(-4.3%) |
| June 2020 | - | $9.92 M(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $13.51 M(+3.7%) |
| Dec 2019 | $13.03 M(+48.2%) | $13.03 M(+8.9%) |
| Sept 2019 | - | $11.96 M(+26.8%) |
| June 2019 | - | $9.43 M(+7.2%) |
| Dec 2018 | $8.79 M(+61.5%) | $8.79 M(-96.0%) |
| Dec 2017 | $5.44 M | - |
| Sept 2017 | - | $220.81 M(+12.6%) |
| June 2017 | - | $196.14 M(-0.3%) |
| Mar 2017 | - | $196.78 M(-1.2%) |
| Dec 2016 | - | $199.08 M(+24.1%) |
| Sept 2016 | - | $160.43 M(-8.3%) |
| June 2016 | - | $174.86 M(-4.9%) |
| Mar 2016 | - | $183.85 M(-9.5%) |
| Dec 2015 | - | $203.13 M(-44.3%) |
| Sept 2015 | - | $364.48 M(-20.0%) |
| June 2015 | - | $455.75 M(+14.7%) |
| Mar 2015 | - | $397.45 M(-25.2%) |
| Dec 2014 | - | $531.18 M |
FAQ
- What is 10x Genomics annual accounts payable?
- What is the all time high annual accounts payable for 10x Genomics?
- What is 10x Genomics annual accounts payable year-on-year change?
- What is 10x Genomics quarterly accounts payable?
- What is the all time high quarterly accounts payable for 10x Genomics?
- What is 10x Genomics quarterly accounts payable year-on-year change?
What is 10x Genomics annual accounts payable?
The current annual accounts payable of TXG is $15.74 M
What is the all time high annual accounts payable for 10x Genomics?
10x Genomics all-time high annual accounts payable is $21.60 M
What is 10x Genomics annual accounts payable year-on-year change?
Over the past year, TXG annual accounts payable has changed by -$5.86 M (-27.14%)
What is 10x Genomics quarterly accounts payable?
The current quarterly accounts payable of TXG is $26.21 M
What is the all time high quarterly accounts payable for 10x Genomics?
10x Genomics all-time high quarterly accounts payable is $531.18 M
What is 10x Genomics quarterly accounts payable year-on-year change?
Over the past year, TXG quarterly accounts payable has changed by +$7.37 M (+39.15%)